Immune Response After SARS-CoV-2 (COVID-19) Vaccination in a Context of Non-Hodgkin Lymphoma

NCT05050461 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
120
Enrollment
OTHER
Sponsor class

Stopped Given the evolution of Covid 19, patient inclusions became very difficult or even non-existent in all participating centers over time

Conditions

Interventions

Sponsor

Versailles Hospital